Come listen to MedSIR Founders Maria Campos, Dr. Javier Cortés, and Dr. Antonio Llombart speak about the MedSIR concept and how we are currently optimizing clinical research in Oncology.

Don’t miss Dr. José Perez, Breast Cancer Specialist, speaking about the role MedSIR plays in his everyday research.

WELCOME TO MEDSIR!

Here we are dedicated to the design and management of clinical trials involving some of the most important current drugs in Oncology such as osimertinib, pembrolizumab, pertuzumab, T-DM1, olaparib, niraparib, eribulin, palbociclib, fulvestrant, radium-223 and many more and we’d be thrilled to help you transform your idea into a high-level strategic clinical trial by applying our simple method:

First off, you confidentially send us your idea… a few lines, or a short synopsis is all we need.

Then, your idea will be reviewed by our network of cancer experts while our statistician develops a realistic scenario for the study to be carried out.

Lastly, we confidentially present the proposal to a potential funder, negotiating a win-win situation that satisfies all parties.

If the project is approved, you will join our team and play a lead role in all study aspects all the way through to the publication of study results. Meanwhile, our clinical operations team professionally manages the trial, respecting ISO 9001-certified quality, while placing a major focus on accrual timelines: The faster we move, the quicker we can produce results and improve patient lives.


INTERVIEW: Oncologist of the Month – Dr Antonio LLombart

Today, we had the chance to sit down with Dr. Antonio Llombart, Breast Cancer Specialist and our “MedSIR Oncologist of the Month” to discuss the exciting...
READ MORE...
NEWS SABCS2017

As always, MedSIR will be back in Texas at the San Antonio Breast Cancer Symposium. Always a special time for MedSIR, this year’s SABCS will be extra special since it will represent MedSIR’s first official exposition...
READ MORE...
PARSIFAL: News

Another huge milestone was achieved this month by MedSIR! The PARSIFAL study finalized the enrollment of its 464 patients in 9 countries in just over 2 years. An amazing feat! It’s really not often that a trial...
READ MORE...

Botón CONTACT US